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Among members of the TGFβ superfamily, bone morphogenetic protein (BMP)
9 and BMP10 regulate vascular endothelium differentiation and morphogenesis by
activating the specific receptor complex, which consists of ALK1 (or ACVRL1),
BMPR2, and endoglin. Mutations in ACVRL1, BMPR2, or ENG are associated with
hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension in
humans [1, 2]. We previously identified TMEM100 as a downstream target gene
of BMP9/BMP10-ALK1 signaling pathway [3]. TMEM100 is a novel intracellular
protein with two putative transmembrane domains, and its amino acid sequence is
highly conserved from fish to humans.
To clarify the physiological significance of TMEM100, we generated Tmem100-
deficient mice and found that all mutant embryos died in utero around embryonic
day 10.5 (E10.5). LacZ reporter driven by the Tmem100 locus was predominantly
expressed in endothelial cells of developing arteries and endocardium. Tmem100
null embryos showed severe vascular dysmorphogenesis and cardiac enlargement
at E9.5 and massive pericardial effusion and growth retardation at E10.5
(Fig. 21.1). These phenotypic abnormalities were virtually identical to those
observed in Alk1/Acvrl1-deficient mice, suggesting that Tmem100 is an important
downstream gene of BMP9/BMP10-ALK1 signaling during cardiovascular
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development. We also demonstrated that Tmem100 null embryos showed atrioven-
tricular canal cushion formation defect, indicating Tmem100 works also as an
important factor for valve and septum morphogenesis.
Taken together, our studies indicate that TMEM100 is a novel endothelial-
specific protein for cardiovascular morphogenesis downstream of BMP9/BMP10-
ALK1 signaling. Clarifying the function of TMEM100 will lead to a better under-
standing of the mechanisms of cardiovascular morphogenesis and the etiologies of
human congenital diseases.
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Fig. 21.1 Tmem100 null embryos at E10.5 show severe cardiovascular dysmorphogenesis,
massive pericardial effusion, and growth retardation (scale bar, 1 mm)
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